17β-HSD12 activators encompass a diverse group of chemical entities that enhance the enzymatic activity of 17β-HSD12, a multifunctional enzyme implicated in the biosynthesis and metabolism of fatty acids and steroids. The functional enhancement of 17β-HSD12 by these activators is achieved through various biochemical interactions that amplify the enzyme's catalytic efficiency. Fatty acids such as arachidonic, linoleic, palmitoleic, docosahexaenoic (DHA), eicosapentaenoic (EPA), and alpha-linolenic acid serve as direct substrates for the enzyme, facilitating its intrinsic elongase activity to produce longer-chain fatty acids, which are critical components of cellular membranes and signaling molecules. The presence of these fatty acids in the cellular milieu increases substrate availability for 17β-HSD12, thereby enhancing the elongation process it catalyzes. Additionally, the enzyme's involvement in steroid metabolism is potentiated by compounds like estrone, progesterone, androstenedione, and 5-alpha-dihydroprogesterone, which it converts to their respective biologically active forms, augmenting the synthesis of essential steroid hormones. These compounds directly enhance the reductase activity of 17β-HSD12 by serving as substrates for the conversion reactions that this enzyme mediates.
Complementing the action of substrate activators, compounds such as NADPH and pyruvate indirectly boost 17β-HSD12 activity by increasing the concentration of essential cofactors. NADPH, in particular, is paramount for the reductase function of the enzyme, and its bioavailability is a critical determinant of 17β-HSD12 enzymatic kinetics. Pyruvate contributes to this pool of cofactors by enhancing NADPH generation through cellular metabolic pathways, indirectly supporting the biosynthetic and metabolic functions of 17β-HSD12. The concerted action of these indirect activators ensures that the enzyme operates at an optimal rate, effectively modulating the synthesis of fatty acids and steroids. The enhancement of 17β-HSD12 activity through these mechanisms has profound implications for the regulation of lipid and hormone levels within the cell, underpinning the pivotal role of these activators in maintaining cellular homeostasis and functionality.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
This polyunsaturated fatty acid can be a substrate for HSD17B12, which is involved in the conversion of arachidonic acid to biologically active eicosanoids. Increased availability of arachidonic acid could enhance HSD17B12 activity. | ||||||
Linoleic Acid | 60-33-3 | sc-200788 sc-200788A sc-200788B sc-200788C | 100 mg 1 g 5 g 25 g | $34.00 $64.00 $166.00 $281.00 | 4 | |
As a substrate for HSD17B12, linoleic acid can be elongated to arachidonic acid. By providing more substrate, HSD17B12’s elongase activity could be enhanced. | ||||||
Palmitoleic acid | 373-49-9 | sc-205424 sc-205424A sc-205424B sc-205424C sc-205424D | 100 mg 500 mg 1 g 5 g 10 g | $33.00 $135.00 $238.00 $1039.00 $1907.00 | 4 | |
This monounsaturated fatty acid could serve as a substrate for the enzyme's role in fatty acid metabolism, potentially enhancing the activity of HSD17B12 in synthesizing longer-chain fatty acids. | ||||||
NADPH tetrasodium salt | 2646-71-1 | sc-202725 sc-202725A sc-202725B sc-202725C | 25 mg 50 mg 250 mg 1 g | $47.00 $84.00 $286.00 $754.00 | 11 | |
As a cofactor for HSD17B12, increased levels of NADPH could enhance the reductase activity of the enzyme, facilitating the conversion of ketone groups to hydroxyl groups in steroid and fatty acid metabolism. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
As a potential substrate for HSD17B12, DHA may be involved in the elongation process of polyunsaturated fatty acids, which could enhance the activity of the enzyme. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
EPA could be another substrate for the elongation process catalyzed by HSD17B12, enhancing the production of longer-chain polyunsaturated fatty acids. | ||||||
α-Linolenic Acid | 463-40-1 | sc-205545 sc-205545A | 50 mg 250 mg | $38.00 $115.00 | 2 | |
As a substrate for HSD17B12, alpha-linolenic acid can be converted to stearidonic acid, a process that could be enhanced by increased levels of this omega-3 fatty acid. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Progesterone could act as a substrate for HSD17B12's role in steroid metabolism, with its availability potentially enhancing the conversion to androgens and estrogens. | ||||||
Pyruvic acid | 127-17-3 | sc-208191 sc-208191A | 25 g 100 g | $41.00 $96.00 | ||
While not a direct substrate, pyruvate can increase cellular NADPH levels via the malic enzyme pathway, which could indirectly enhance HSD17B12 activity by providing more cofactor for its enzymatic reactions. | ||||||